Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.15
0.00 (0.00%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $155.76 million as of September 6, 2024.
Market Cap
155.76M
Enterprise Value
253.89M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has increased from $152.13M to $155.76M, an increase of 2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2024 | 156.20M | 2.68% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 161.36M |
| Cybin | 159.76M |
| Alpha Tau Medical | 159.08M |
| Lineage Cell Therapeutics | 157.87M |
| MultiPlan | 157.56M |
| Caribou Biosciences | 155.42M |
| 23andMe Holding Co. | 153.73M |
| Ventyx Biosciences | 153.35M |